Global (United States, European Union and China) Amantadine Market Research Report 2019-2025
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Amantadine Quarterly Market Size Analysis
- 2.1 Amantadine Business Impact Assessment - COVID-19
- 2.1.1 Global Amantadine Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.1.2 Global Amantadine Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Amantadine Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 Global Amantadine Quarterly Market Size by Manufacturers, 2019 VS 2020
- 3.2 Global Amantadine Factory Price by Manufacturers
- 3.3 Location of Key Manufacturers Amantadine Manufacturing Factories and Area Served
- 3.4 Date of Key Manufacturers Enter into Amantadine Market
- 3.5 Key Manufacturers Amantadine Product Offered
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Amantadine Segments, By Type
- 4.1 Introduction
- 1.4.1 High Purity
- 1.4.2 Low Purity
- 4.2 By Type, Global Amantadine Market Size, 2019-2021
- 4.2.1 By Type, Global Amantadine Market Size by Type, 2020-2021
- 4.2.2 By Type, Global Amantadine Price, 2020-2021
5 Impact of Covid-19 on Amantadine Segments, By Application
- 5.1 Overview
- 5.5.1 Tablets Product
- 5.5.2 Oral Solution
- 5.5.3 Others
- 5.2 By Application, Global Amantadine Market Size, 2019-2021
- 5.2.1 By Application, Global Amantadine Market Size by Application, 2019-2021
- 5.2.2 By Application, Global Amantadine Price, 2020-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Chemoswed AB
- 7.1.1 Chemoswed AB Business Overview
- 7.1.2 Chemoswed AB Amantadine Quarterly Production and Revenue, 2020
- 7.1.3 Chemoswed AB Amantadine Product Introduction
- 7.1.4 Chemoswed AB Response to COVID-19 and Related Developments
- 7.2 Rochem International Inc
- 7.2.1 Rochem International Inc Business Overview
- 7.2.2 Rochem International Inc Amantadine Quarterly Production and Revenue, 2020
- 7.2.3 Rochem International Inc Amantadine Product Introduction
- 7.2.4 Rochem International Inc Response to COVID-19 and Related Developments
- 7.3 Apeloa Pharmaceutical Co
- 7.3.1 Apeloa Pharmaceutical Co Business Overview
- 7.3.2 Apeloa Pharmaceutical Co Amantadine Quarterly Production and Revenue, 2020
- 7.3.3 Apeloa Pharmaceutical Co Amantadine Product Introduction
- 7.3.4 Apeloa Pharmaceutical Co Response to COVID-19 and Related Developments
- 7.4 Hangzhou Longshine Bio-Tech Co
- 7.4.1 Hangzhou Longshine Bio-Tech Co Business Overview
- 7.4.2 Hangzhou Longshine Bio-Tech Co Amantadine Quarterly Production and Revenue, 2020
- 7.4.3 Hangzhou Longshine Bio-Tech Co Amantadine Product Introduction
- 7.4.4 Hangzhou Longshine Bio-Tech Co Response to COVID-19 and Related Developments
- 7.5 Northeast Pharmaceutical Group Co
- 7.5.1 Northeast Pharmaceutical Group Co Business Overview
- 7.5.2 Northeast Pharmaceutical Group Co Amantadine Quarterly Production and Revenue, 2020
- 7.5.3 Northeast Pharmaceutical Group Co Amantadine Product Introduction
- 7.5.4 Northeast Pharmaceutical Group Co Response to COVID-19 and Related Developments
- 7.6 Zhejiang Apeloa Kangyu Pharmaceutical Co
- 7.6.1 Zhejiang Apeloa Kangyu Pharmaceutical Co Business Overview
- 7.6.2 Zhejiang Apeloa Kangyu Pharmaceutical Co Amantadine Quarterly Production and Revenue, 2020
- 7.6.3 Zhejiang Apeloa Kangyu Pharmaceutical Co Amantadine Product Introduction
- 7.6.4 Zhejiang Apeloa Kangyu Pharmaceutical Co Response to COVID-19 and Related Developments
- 7.7 Jiangxi Dongxu Chemical Science And Technology Co
- 7.7.1 Jiangxi Dongxu Chemical Science And Technology Co Business Overview
- 7.7.2 Jiangxi Dongxu Chemical Science And Technology Co Amantadine Quarterly Production and Revenue, 2020
- 7.7.3 Jiangxi Dongxu Chemical Science And Technology Co Amantadine Product Introduction
- 7.7.4 Jiangxi Dongxu Chemical Science And Technology Co Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
- 8.1 Amantadine Supply Chain Analysis
- 8.1.1 Amantadine Supply Chain Analysis
- 8.1.2 Covid-19 Impact on Amantadine Supply Chain
- 8.2 Distribution Channels Analysis
- 8.2.1 Amantadine Distribution Channels
- 8.2.2 Covid-19 Impact on Amantadine Distribution Channels
- 8.2.3 Amantadine Distributors
- 8.3 Amantadine Customers
9 Key Findings
10 Appendix
- 10.1 About Us
This report covers market size and forecasts of Amantadine, including the following market information:
Global Amantadine Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Amantadine Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Amantadine Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Amantadine Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (MT)
Key market players
Major competitors identified in this market include Chemoswed AB, Rochem International Inc, Apeloa Pharmaceutical Co, Hangzhou Longshine Bio-Tech Co, Northeast Pharmaceutical Group Co, Zhejiang Apeloa Kangyu Pharmaceutical Co, Jiangxi Dongxu Chemical Science And Technology Co, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
High Purity
Low Purity
Based on the Application:
Tablets Product
Oral Solution
Others